BMS-929075 |
| Katalog-Nr.GC70501 |
BMS-929075 ist ein potenter und oral aktiver HCV NS5B Replikat-allosterischer Inhibitor an der Palmenstelle.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1217338-97-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
BMS-929075 (0-60 µM) shows cytotoxicity with CC50 values of 60, >12.5, >50 µM for Huh-7, HepG2, primary human hepatocytes, respectively[1].
BMS-929075 (compound 37) (2 mg/kg for i.v.; 6 mg/kg for p.o.) shows good pharmacokinetic parameters with oral bioavailability of 48% in rats[1].
Pharmacokinetic Parameters of BMS-929075 in Male Sprague-Dawley rats[1].
| IV | PO | |||||||||
| species | Cl (mL/min/kg) | IV t1/2(hr) | Vss(L/kg) | Cmax(µM) | Tmax(hr) | AUC (µM h) | C6 liver (µM) | C24 liver (µM) | C24 liver/plasma (µM) | F% (mL/min/kg) |
| rat | 1.7 | 4.7 | 0.7 | 7.5 | 4 | 54.5 | 15.1 | 1.12 | 1.6 | 48 |
References:
[1]. Yeung KS, et al. Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies. J Med Chem. 2017 May 25;60(10):4369-4385.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *